Clinical Trial Update: Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low-dose radiotherapy with concurrent chemotherapy and serplulimab for extensive-stage small-cell lung cancer; the study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Sichuan University | Conditions: Extensive-stage Small-cell Lung Cancer | Phase 2 | Status: RECRUITING